Share Facebook Twitter Email In this phase I/II trial, low dose radiation (0.5 Gy BID) was used during monthly temozolomide cycles for patients with recurrent high grade gliomas after prior RT to potentiate TMZ effects. | Lin, Int J Radiat Oncol Biol Phys 2025 TMZ
